Author

M. Abdelrahim

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Design and development of a delayed-release dose-flexible matrix tablet of tolfenamic acid for potential application in cancer therapy.

Tolfenamic acid (TFA), a Biopharmaceutics Classification System (BCS) class II drug, exhibits dissolution-limited absorption and significant gastric irritation when administered as conventional immediate-release formulations, limiting its potential for high-dose and long-term applications, including emerging anticancer...

B. P. Dongala, M. Nutan, M. Abdelrahim et al. · International journal of pha... · 0 citations

Review Open access Sep 2026

ctDNA in the Management of Resectable & Advanced Colorectal Cancer: Current Status and Future Directions

Abstract Circulating tumor DNA (ctDNA) is an increasingly important biomarker for molecular residual disease (MRD) after curative-intent treatment of colorectal cancer (CRC), but its prognostic value must be distinguished from proven clinical utility. This structured narrative review synthesizes evidence from PubMed/ME...

H. Al-Shamsi, S. Rafii, S. Tirmazy et al. · OncoTargets and Therapy · 0 citations

Open access Aug 2026

Survival Outcomes of Elderly Patients with Stage III Colon Cancer: Insights from a Comprehensive Cancer Center in the Middle East

Background: Colon cancer is the fourth most commonly diagnosed cancer worldwide, with elderly individuals accounting for nearly one-third of new cases. While adjuvant chemotherapy has been associated with improved survival outcomes; its effectiveness in elderly patients remains unclear. This retrospective study was con...

Yacob Saleh, Suhaib Khater, T. Alawabdeh et al. · Jordan Medical Journal · 0 citations